Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 AUD | 0.00% | -7.37% | +27.54% |
May. 17 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
May. 15 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.54% | 348M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.21% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data